Translational development of a targeted and stroma-breaking nanoparticle drug for pancreatic cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- R43CA246827
- Recipient
-
Migra-Therapeutics, LLC UEI NCN6HK3N2SG3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $223,950
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Georgia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $238 | |
| Amendment | -$238 | |
| Amendment | -$238 | |
| Amendment | -$238 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,425 |
Quick answers
Who received award R43CA246827?
R43CA246827 was awarded to Migra-Therapeutics, LLC by National Cancer Institute (National Institutes of Health) on September 19, 2019.
How much is award R43CA246827 worth?
$223,950 has been obligated on R43CA246827.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award